NSW skin trial starts in Jul, PATY Queensland winner announced, CPS reps at PCS24, Blooms The Chemist pushback on vapes, Beauty & Wellness, and more
Click here to download Pharmacy Daily for Thursday 27th June 2024
NSW skin trial starts in Jul, PATY Queensland winner announced, CPS reps at PCS24, Blooms The Chemist pushback on vapes, Beauty & Wellness, and more
Click here to download Pharmacy Daily for Thursday 27th June 2024
SIGMA Healthcare Limited’s share price has surged this week, reaching $2.06, up from $1.46 seven days ago.
JARDIANCE (empagliflozin) has become the first oral treatment to be available on private script for type 2 diabetes (T2D) in children and adolescents, since metformin was indicated for use in this growing patient group.
PRICELINE is set to undergo a rebrand next month to reflect its strategy combining beauty with health expertise and value.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.